Sunday, 29 November 2020

Nanavati Super Speciality Hospital ropes in Manpreet Sohal as Director

09 December 2019 | News

During his tenures at Gleneagles Global Hospitals and Fortis Healthcare, he excelled in hospital operations

Nanavati Super Speciality Hospital (NSSH) has announced the appointment of senior healthcare professional Manpreet Sohal as its Director and Chief Operating Officer (COO). Prior to Nanavati Hospital, Sohal was CEO of Gleneagles Global Hospitals and Zonal Director of Fortis Healthcare, Mumbai. He is credited with over 24 years of professional experience, including 10 years in Senior Health Care Management.

During his tenures at Gleneagles Global Hospitals and Fortis Healthcare, he excelled in hospital operations and improved the quality of care, physician & medical staff relations, supply chain management and total project management including medical equipment procurement and manpower sourcing.

Sohal completed his Bachelor’s Degree in Law from Punjab University and Healthcare Delivery Management program from Harvard Business School. He assumed the office of Director & COO at NSSH from November 30, 2019.

Abhay Soi, Chairman & Managing Director, Radiant Life Care Private Limited said, “We are pleased to welcome Mr Sohal as the COO and Director of Nanavati Super Speciality Hospital. His dynamic leadership qualities, operational focus and strong strategic perspective are well compatible with our great institution. Mr Sohal’s appointment will accelerate our mission to offer qualitative medical services with compassionate care.”

During his career, Mr. Sohal has worked extensively with large healthcare chains such as Fortis Healthcare where he was the Zonal Director, Mumbai. In that role he functioned as CEO of Fortis SL Raheja Hospital. Medical Facilities such as Punjab Institute of Medical Sciences (PIMS), Hiranandani Hospital, Navi Mumbai (A PPP project) and Jessaram Hospital, New Delhi have flourished under Mr. Sohal’s leadership.




× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls